Clinical and serologic manifestations of autoimmune disease in MRL- lpr/lpr mice lacking nitric oxide synthase type 2

Journal of Experimental Medicine

Volumn 186, Issue 3, 1997, Pages 365-373

  Gilkeson, Gary S ^a   Mudgett, John S ^b   Seldin, Michael F ^c   Ruiz, Phil ^d   Alexander, Audrey A ^e   Misukonis, Mary A ^e   Pisetsky, David S ^e   Weinberg, J Brice ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL TYPE; GENE DISRUPTION; GENETIC HETEROGENEITY; GENETIC RECOMBINATION; INFLAMMATORY CELL; MEDIATOR RELEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SEROLOGY;

ANIMALS; ARTHRITIS; AUTOIMMUNE DISEASES; FEMALE; GLOMERULONEPHRITIS; IMMUNOBLOTTING; KIDNEY; LIVER; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SPLEEN;

EID: 0030878992     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.3.365     Document Type: Article

References (36)

1. Cohen, P.L., and R.A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
2. Andrews, B.S., R.A. Eisenberg, A.N. Theofilopoulos, S. Izui, C.B. Wilson, P.J. McConahey, E.D. Murphy, J.B. Roths, and F.J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunological manifestations in several strains. J. Exp. Med. 148:1198-1215.
3. Hang, L., A.N. Theofilopoulos, and F.J. Dixon. 1982. A spontaneous rheumatoid arthritis-like disease in MRL-1 mice. J. Exp. Med. 155:1690-1701.
4. Moyer, C.F., J.D. Strandberg, and C.L. Reinisch. 1987. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am. J. Pathol. 127:229-242.
5. Nose, M., M. Nishimura, and M. Kyogoku. 1989. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis. Am. J. Pathol. 135:271-80.
6. Watson, M.L., J.K. Rao, G.S. Gilkeson, P. Ruiz, E.M. Eicher, D.S. Pisctsky, A. Matsuzawa, J.M. Rochelle, and M.F. Seldin. 1992. Generic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645-1656.
7. G-monomethyl-L-arginine. J. Exp. Med. 179:651-660.
8. Privalle, C.T., T. Keng, G.S. Gilkeson, and J.B. Weinberg. 1996. The role of nitric oxide and peroxynitrite in the pathogenesis of spontaneous murine autoimmune disease. In The Biology of Nitric Oxide. Vol. 5. J. Stamler, S.S. Gross, and S. Moncada, editors. Portland Press, London. 20.
9. Oates, J.C., P. Ruiz, A. Alexander, A.M.M. Pippen, and G.S. Gilkeson. 1997. Effect of late modulation of nitric oxide production on murine lupus. Clin. Immnnol. Immunopath. 83: 86-92.
10. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
11. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Eng. J. Med. 329:2002-2012.
12. Nathan, C.F., and J.B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
13. Hibbs, J., Jr. 1991. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res. Immunol. 142:565-569.
14. Clancy, R.M., and S.B. Abramson. 1995. Nitric oxide - a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 210:93-101.
15. Tamir, S., T. Derojaswalker, A. Gal, A.H. Weller, X.T. Li, J.G. Fox, G.N. Wogan, and S.R. Tannenbaum. 1995. Nitricoxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice. Cancer Res. 55:4391-4397.
16. Huang, F.P., G.J. Feng, G. Lindop, D.I. Stott, and F.Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL: MP-lpr:lpr mice. J. Exp. Med. 183:1447-1459.
17. Farrell, A.J., D.R. Blake, R.M. Palmer, and S. Moncada. 1992. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1219-1222.
18. Sakurai, H., H. Kohsaka, M.F. Liu, H. Higashiyama, Y. Hirata, K. Kanno, I. Saito, and N. Miyasaka. 1995. Nitricoxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96:2357-2363.
19. St. Clair, E.W., W.E. Wilkinson, T. Lang, L. Sanders, M.A. Misukonis, G.S. Gilkeson, D.S. Pisetsky, D.L. Granger, and J.B. Weinberg. 1996. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J. Exp. Med. 184:1173-1178.
20. Macmicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J.S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650.
21. Wei, X.Q., I.G. Charles, A. Smith, J. Ure, C.J. Feng, F.P. Huang, D.M. Xu, W. Muller, S. Moncada, and F.Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (Lond.). 375:408-411.
22. Laubach, V.E., E.G. Shesely, O. Smithies, and P.A. Sherman. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA. 92:10688-10692.
23. Mixter, P.F., J.Q. Russell, F.H. Durie, and R.C. Budd. 1995. Decreased CD4-CD8-TCR-alpha beta + cells in lpr/ lpr mice lacking beta 2-microglobulin. J. Immunol. 154:2063-2074.
24. Anstey, N.M., J.B. Weinberg, M. Hassanali, E.D. Mwaikambo, D. Manyenga, M.A. Misukonis, D.R. Arnelle, D. Hollis, M.I. McDonald, and D.L. Granger. 1996. Nitric oxide in Tanzanian children with malaria. Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184:557-567.
25. Stamler, J.S., D.J. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science (Wash. DC). 258:1898-1902.
26. G-monomethyl-L-arginine. J. Immunol. 146:1294-1302.
27. Granger, D.L., W.C. Miller, and J.B. Hibbs, Jr. 1996. Methods of analyzing nitric oxide production in the immune response. In Methods in Nitric Oxide Research. M. Feelisch and J.S. Stamler, editors. John Wiley & Sons, Ltd., New York. 603-617.
28. Hibbs, J.B., Jr., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R.L. Baranowski, J.H. Ward, R.L. Menlove, M.P. McMurry, J.P. Kushner, and W.E. Samlowski. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy (erratum published 90:295). J. Clin. Invest. 89:867-877.
29. Takahashi, S., M. Nose, J. Sasaki, T. Yamamoto, and M. Kyogoku. 1991. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J. Immunol. 147: 515-519.
30. Mulligan, M.S., S. Moncada, and P.A. Ward. 1992. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Brit. J. Pharmacol. 107:1159-62.
31. Mulligan, M.S., J.S. Warren, C.W. Smith, D.C. Anderson, C.G. Yeh, A.R. Rudolph, and P.A. Ward. 1992. Lung injury after deposition of IgA immune complexes. Requirements for CD 18 and L-arginine. J. Immunol. 148:3086-3092.
32. Genaro, A.M., S. Hortelano, A. Alvarez, C. Martineza, and L. Bosca. 1995. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest. 95:1884-1890.
33. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature (Lond.). 377:348-351.
34. Warren, R.W., S.A. Caster, J.B. Roths, E.D. Murphy, and D.S. Pisetsky. 1984. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin. Immunol. Immunopath. 31:65-77.
35. Berney, T., T. Fulpius, T. Shibata, L. Reininger, J. Van Snick, H. Shan, M. Weigert, A. Marshak-Rothstein, and S. Izui. 1992. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int. Immunol. 4: 93-99.
36. Southan, G.J., and C. Szabo. 1996. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51:383-394.